Self Containing Enclosure for Protection from Killer Bees
A self contained protective enclosure with an opening for entry and egress and a screen for ventilation and viewing.
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7687553 | Method for treating bone cancer pain or chemotherapy induced pain The present invention is directed to the use of a class of peptide compounds for treating tumor pain, in particular bone cancer pain, for treating chemotherapy-induced pain and for treating nucleoside-induced pain. ... | 03/30/2010 |
| 7632859 | Iontophoretic delivery of rotigotine for the treatment of Parkinson's disease By using a composition comprising rotigotine and at least one chloride salt in a concentration of 1 to 140 mmol/l, the composition having a pH of 4 to 6.5 in a iontophoretic device for the treatment of Parkinson's disease, it became possible to obtain a rotigotine f... | 12/15/2009 |
| 7427601 | Method for treating tremor The present invention is directed to the use of a class of peptide compounds for treating essential tremor and other tremor syndromes. ... | 09/23/2008 |
| 7416864 | Method for treating dyskinesia The present invention is directed to the use of a class of peptide compounds for treating primary or/and secondary dyskinesias such as tardive dyskinesia. ... | 08/26/2008 |
| 7384980 | Derivatives of 3,3-diphenylpropylamines The invention concerns novel derivatives of 3,3-diphenylpropylamines, methods for their preparation, pharmaceutical compositions containing the novel compounds, and the use of the compounds for preparing drugs. More particularly, the invention relates to novel prodr... | 06/10/2008 |
| 7309497 | Injectable pharmaceutical composition for systematic administration of pharmacologically active ingredients The invention relates to novel pharmaceutical compositions for the systemic administration of pharmacologically active ingredients. The invention relates in particular to an injectable pharmaceutical composition comprising (a) a pharmacologically active ingredient i... | 12/18/2007 |
| 7230030 | Derivatives of 3,3-diphenylpropylamines The invention concerns novel derivatives of 3,3-diphenylpropylamines, methods for their preparation, pharmaceutical compositions containing the novel compounds, and the use of the compounds for preparing drugs. More particularly, the invention relates to novel prodr... | 06/12/2007 |
| 6809225 | Method for producing 3,3-diarylpropylamines A novel method is described for producing 3,3-diarylpropylamines by hyroformylation/hydrocarbonylation and then reductive amination using a transition metal catalyst. ... | 10/26/2004 |
| 6803481 | Use of peptide class of compound for treating non neuropathic inflammatory pain The present invention concerns the use of compounds of the Formula (I) for treating different types and symptoms of acute and chronic pain, especially non neuropathic inflammatory pain in mammals. The pain to be treated may be e.g. chronic inflammatory pain, rheumat... | 10/12/2004 |
| 6783769 | Transdermal therapeutic system TTS containing tolterodine The invention relates to a transdermal therapeutic system (TTS) for transcutaneously administering tolterodine over a period of several days and to a method for producing the same. The TTS contains a self-adhesive layer-shaped matrix composition which contains a (me... | 08/31/2004 |
| 6713464 | Derivatives of 3,3-diphenylpropylamines The invention concerns novel derivatives of 3,3-diphenylpropylamines, methods for their preparation, pharmaceutical compositions containing the novel compounds, and the use of the compounds for preparing drugs. More particularly, the invention relates to novel prodr... | 03/30/2004 |
| 6562367 | Transdermal therapeutic system (TTS) for administering sexual steroid hormones A transdermal therapeutic system for transcutaneous administration of sexual steroid hormones over long time periods, and a solvent-free method for the production thereof, is disclosed. The steroid hormones are subjected to as little thermal exposure as p... | 05/13/2003 |
| 6555131 | Therapeutical system for transdermal delivery of levonorgestrel A stable therapeutical transdermal system for the transcutaneous delivery of levonorgestrel, alone or together with other sex steroid hormones, over a long time period is disclosed. A method of producing the transdermal system that avoids the use of solve... | 04/29/2003 |
| 6555129 | Transdermal therapeutic system (TTS) containing oxybutynin A transdermal therapeutic system (TTS) for transcutaneous administration of oxybutynin over a period of several days, in addition to a method for the production of the TTS without the use of solvents, are disclosed. The TTS contains a matrix mass containi... | 04/29/2003 |
| 6461636 | Transdermal therapeutic system containing pergolide The invention relates to a transdermal therapeutic system (TTS) for the transcutaneous administration of pergolide over several days and to a method for its manufacture without using solvents. The TTS contains a matrix mass, containing pergolide and takin... | 10/08/2002 |
| 6284754 | Pharmaceutical compositions containing 1-oleylazacycloheptan-2-one as enhancing agent of transport across biological membranes The invention relates to pharmaceutical compositions for topical application containing at least one physiologically active agent and an effective amount of 1-oleylazacycloheptan-2-one as the human or animal epithelial membrane permeability enhancer, to t... | 09/04/2001 |
| 6248355 | Pharmaceutical composition containing an acid-labile omeprazole and process for its preparation A composition, particularly adapted for oral administration, containing omeprazole, and a method for preparing the composition, are disclosed. The composition, being exempt of alkaline-reacting compounds, contains a core constituted of nuclei and said ben... | 06/19/2001 |
| 6207198 | Composition containing an acid-labile omeprazole and process for its preparation A composition, particularly adapted for oral administration, containing omeprazole, and a method for preparing the composition, are disclosed. The composition, being exempt of alkaline-reacting compounds, contains a core constituted of nuclei and said ben... | 03/27/2001 |
| 6103769 | Pharmaceutical composition containing nitric oxide Disclosed are pharmaceutical composition of a sterile, injectable physiologically acceptable solution containing nitric oxide (NO), processes for preparing the compositions and a process for detecting physiologically present NO. With these NO solutions, N... | 08/15/2000 |
| 5929196 | Polyesters of a polyhydroxycarboxylic acid and a polyol having a substituent with electrolyte properties The invention relates to new polyesters of a polyol containing substituents with electrolyte properties with polymeric hydroxycarboxylic esters, their method of preparation and their use. The polyesters are particularly suitable for use in the preparation... | 07/27/1999 |
| 5873860 | Injection device The invention concerns a complete injection device which is ready for immediate use and whose injection member charged with an active substance solution and cannula form an inseparable unit. The invention also concerns a blister pack comprising at least t... | 02/23/1999 |
| 5744124 | Nitroglycerin-containing hydrophilic aqueous pumpable spray composition A hydrophilic aqueous pump spray composition for treating angina pectoris comprising 0.15 to 0.50 weight/% of nitroglycerin, 24.50 to 24.85 weight/% of ethanol, 32.00 weight/% of 1,2-propyleneglycol and 43.00 weight/% of purified water and having a pH of ... | 04/28/1998 |
| 5648096 | Process for the production of microcapsules A method for the production of microcapsules embedded with pharmaceuticals, peptides, proteins, enzymes and vaccines, which uses biodegradable solvents, and microcapsules free of toxic residual solvents is described. The microcapsules are obtained by spra... | 07/15/1997 |
| 5628773 | Microsleeves and electric supply leads A device for producing a micro connection element 24, 30, the device comprising a cylindrical outer sleeve 1, a cylindrical central element 2 arranged coaxially in the outer sleeve 1, a plurality of cylindrical spacers 3 arranged between the outer sleeve ... | 05/13/1997 |
| 5603948 | Active ingredient patch for low-melting and/or volatile active ingredients A method of preparing a patch for the controlled release of readily available volatile active substances to the skin is disclosed. The patch comprises a back layer, and, bonded to the back layer, a water-insoluble adhesive film consisting of a pressure-se... | 02/18/1997 |
| 5527536 | Active ingredient patch for low-melting and/or volatile active ingredients The invention concerns a patch for the controlled release of readily available volatile active substances to the skin, the patch comprising a back layer and, bonded to it, a water-insoluble adhesive film consisting of a pressure-sensitive fusion adhesive,... | 06/18/1996 |
| 5498418 | Nitroglycerine plaster and process for its production The invention relates to a dermal plaster for the transdermal provision of nitroglycerin comprising a carrier film and a removable protective film and an adhesive mass containing nitroglycerine on the basis of a cross-linked acrylate-vinyl acetate copolym... | 03/12/1996 |
| 5472710 | Pharmaceutical preparation to be administered orally with controlled release of active substance and method for its manufacture Pharmaceutical preparation to be administered orally with controlled release of active substance and method for its manufacture. Pharmaceutical preparation to be administered orally with controlled release of active substance, containing a nucleus which i... | 12/05/1995 |
| 5428061 | Organic nitrates and method for their preparation New organic nitrate compounds, formed by condensing a nitrato alkanoic acid with a sulfur-containing amino acid or peptide, which prevent nitrate tolerance or overcome existing tolerance and which are useful for the treatment of cardiac diseases including... | 06/27/1995 |
| 5424076 | Method of producing microscopic particles made of hydrolytically decomposable polymers and containing active substances The invention concerns a method for the production of microscopic particles made of hydrolytically decomposable polymers, in particular copolymers, and containing active substances, using fluid gas with a uniform particle-size distribution and by the addi... | 06/13/1995 |
| 5398405 | Microconnectors electric supply leads using them and method of manufacture A device for producing a micro connection element 24, 30, the device comprising a cylindrical outer sleeve 1, a cylindrical central element 2 arranged coaxially in the outer sleeve 1, a plurality of cylindrical spacers 3 arranged between the outer sleeve ... | 03/21/1995 |
| 5393529 | Estrogen-containing active substance plaster The present invention relates to active substance plasters for the controlled release of active substances to the skin consisting of a backing layer, an adhesive film connected therewith which film is water-soluble and consists of pressure-sensitive adhes... | 02/28/1995 |
| 5370862 | Pharmaceutical hydrophilic spray containing nitroglycerin for treating angina A pharmaceutical aerosol spray for treating an angina attack including a container having a liquid composition therein comprising 0.1 to 2 weight percent of nitroglycerin, 2 to 60 weight percent of ethanol, 2 to 60 weight percent of propylene glycol, 10 t... | 12/06/1994 |
| 5325584 | Microconnectors, electric supply leads using them and method of manufacture A device for producing a micro connection element 24, 30, the device comprising a cylindrical outer sleeve 1, a cylindrical central element 2 arranged coaxially in the outer sleeve 1, a plurality of cylindrical spacers 3 arranged between the outer sleeve ... | 07/05/1994 |
| 5284872 | Nitrato alkanoic acid derivatives, methods for their production, pharmaceutical compositions containing the derivatives and medicinal uses thereof New organic nitrate compounds, formed by condensing a nitrato alkanoic acid with a sulfur-containing amino acid or peptide followed by the reaction of the resulting product with an amino acid, N-acylamino acid, peptide or an N-acyl peptide to produce a th... | 02/08/1994 |
| 5043280 | Method and apparatus for the manufacture of a product having a substance embedded in a carrier A sterile product containing a substance embedded in a carrier is produced by use of a supercritical gas. In one embodiment, a mixture is formed of a substance, carrier and supercritical gas such as nitrous oxide or carbon dioxide, and the supercritical g... | 08/27/1991 |